ASX ANNOUNCEMENT INVION AND PERCHERON TO EXPLORE NOVEL COMBINATION OF VISTA IMMUNOTHERAPIES AND PHOTOSOFT™ FOR CANCER • Invion and Percheron Therapeutics to undertake preclinical studies evaluating HMBD- 002, a type of immunotherapy, specifically a VISTA immune checkpoint inhibitor (ICI), in...